KYTX
Kyverna Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.25
−1.20%Leverage
- Debt / equity
- 0.20x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -0.22x
- Net debt / EBITDA
- -0.01x
Liquidity & coverage
- Current ratio
- 9.06x
- Quick ratio
- 9.06x
- Cash ratio
- 8.75x
- Interest coverage
- -88.69x
- EBITDA / interest
- -83.30x
- Working capital
- $183.7M
Cash & dividend
- FCF / debt
- -4.83x
- Cash flow / debt
- -4.81x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026